Background: Pain, stiffness and deformity of the feet are related to reduced mobility and participation restrictions in daily activities in patients with established rheumatoid arthritis (RA). The new biological medications are effective and reduce disease activity, but not disability to the same extent. Foot problems are assumed to be related to participation restrictions also in patients with early RA, diagnosed after the introduction of biological medications, hindering for example physical activity. Hence, there is a need for more knowledge about foot problems in order to identify possible needs for rehabilitative interventions. Objectives: To explore disability related to foot problems in women and men with early rheumatoid arthritis and its relation to participation in daily life. Methods: 59 patients (58% women, 20-63 years) with early RA were interviewed about participation dilemmas in daily life related to RA, using Critical Incident Technique. The interviews were audio-recorded and transcribed. Data related to foot problems were extracted and analysed thematically. A research partner with RA validated the retrieved categories. The study was approved by the Regional Ethics Committee. Results: More than 2/3 of the patients mentioned that they had participation restrictions related to foot problems. The analysis revealed 5 categories concerning foot problems and the relation to participation restrictions: 1) foot problems as an early indicator of the disease, 2) hindrance in managing the daily routine and house hold activities, 3) struggling to be mobile, 4) difficulties in doing a god job at work and 5) difficulties in participating in recreation and leisure activities. Both women and men shared many experiences, as difficulties to be physically active. Several women expressed difficulties to use the shoes they wanted. Being able to move on uneven ground in, for example, the forest was something that many men expressed as difficult.
behavioural therapy (CBT), which focuses on psychological flexibility and behavior change. ACT has been advocated for the treatment of Persistent Pain. A systematic review concluded that ACT is efficacious for enhancing physical functioning and decreasing distress amongst adults with chronic pain attending Pain Rehabilitation Programmes (Hann & McCracken 2014) . A call was made for further studies to examine outcomes from more homogenous groups. Objectives: To assess the effects of an eight-week group ACT, Rheumatology based programme, for people with persistent pain, on pain acceptance, activity engagement, psychological distress and self-efficacy. Methods: Patients were referred to the programme by three Consultant Rheumatologists over a five-year period. Over one hundred patients' outcome measures were available for this retrospective study from a convenience sample. Consent had been sought routinely from patients who attended the ACT programme and ethical approval was granted from the Hospital Research Ethics Committee (REC) and Ulster University REC. Baseline measures were taken at assessment, on the final day of the programme and at the follow up six-month review. Data was analysed with One Way Repeated Measures ANOVA using SPSSv20. Effect sizes were calculated using Partial Eta Squared and interpreted using the guidelines proposed by Cohen (1998) . Results: For those with scores at all three time points, mean depression scores, anxiety scores and self-efficacy scores were statistically significantly different over time. In addition, for those with activity engagement and pain willingness scores at all three time points, scores were statistically significantly different over time. Objectives: To determine the reliability, responsiveness and interpretability of the AAQ. Methods: In 6 European countries the AAQ was completed twice on a computer with a 7 days interval by 238 patients (DK (36), FR (37), IT (51), NL (39), SP (36), UK (39)). Reliability was assessed by calculating internal consistency (Cronbach's alpha), the intra-class correlation coefficient (ICC), the Standard Error of Measurement (SEM) and the Smallest Detectable Change (SDC). In the Netherlands, an additional group of 92 patients were followed for 6 months in order to assess responsiveness. Data from the AAQ, a PROM (the Hip disability or Knee injury Osteoarthritis Outcome Score, ADL subscore), and performance-based tests (the Timed Up and Go test, Stair Climbing Test and 30 seconds Chair Stands Test) were collected. To estimate the Minimal Important Change (MIC) of the AAQ an anchor-based MIC distribution method was used with a Global Rating of Change (GRC) as anchor. The Receiver Operating Characteristic (ROC) method was used to find the AAQ change score that best discriminates between patients who improved in activity limitations and who are not. The MIC was compared to the SDC in order to facilitate the interpretation of change scores. Results: Cronbach's alpha was o.94. ICC for test-retest reliability was 0.93 (95% CI: 0.91-0.95). SEM and SDC were 4.9% and 13.5%, respectively. With regard to responsiveness the change scores of the AAQ after 6 months correlated 0.58 with the PROM, 0.42-0.55 with the performance based tests, and 0.46 with GRC. The ROC curve showed an area under the curve of 0.72 with a sensitivity of 63% and a specificity of 81% for the optimal MIC of 9.1 for discrimination. The MIC was smaller than the SDC meaning that the change is important but cannot be distinguished from measurement error in individual patients.
Conclusions:
The AAQ, measuring a new construct in the domain physical functioning in addition to a PROM and performance-based tests, showed good construct validity, cross-cultural validity, internal consistency and test-retest reliability. A change in AAQ score over 13.5% indicates a real improvement in activity limitations in HKOA patients. The AAQ seems to have great potential for international use in research but the application in clinical practice needs caution. Background: A substantial number of people with a rheumatic disease perceive invalidation consisting of "lack of understanding" and "discounting" (negative social responses) [1] . Our study was guided by the notion that high self-efficacy will make people feel competent to deal with situations in which control of invalidation is possible and likely to be successful. In other situations, high acceptance will help people to actively and in full awareness experience even adverse situations such as invalidation without unnecessary attempts to change their frequency or form, which is considered a core aspect of acceptance. Objectives: To get insight into the potential buffering role of self-efficacy and pain acceptance against invalidation, we examined the association of self-efficacy and pain acceptance with invalidation in people with diverse rheumatic diseases. Methods: The design was cross-sectional. Spanish speaking people (N=1153, 91% female, mean age 45±11 years) with one or multiple rheumatic diseases completed online versions of the Illness Invalidation Inventory [2], the Chronic Pain Acceptance Questionnaire, and the Chronic Disease Self-Efficacy Scale.
Results: Before and after adjustment for age, gender, education, and fibromyalgia diagnosis, higher self-efficacy and higher pain acceptance were independently associated with discounting and lower lack of understanding (P<0.001, see Figure) . The combined occurrence of high self-efficacy and high acceptance was associated most clearly with lower lack of understanding (interaction: P=0.03) and with discounting (interaction: P=0.07, not reaching statistical significance): see Figure. Conclusions: The present study convincingly shows that self-efficacy and pain acceptance are associated with less invalidation. This suggests the usefulness of examining in prospective studies whether interventions aimed at increasing self-efficacy and pain acceptance can help people with rheumatic diseases for whom invalidation is a considerable burden. A cognitive-behavioral model including self-efficacy and acceptance to deal with invalidation is proposed. 
